The National Formulary of India (NFI) is a comprehensive reference guide developed by the Indian Pharmacopoeia Commission (IPC) to support healthcare professionals in the rational use of medicines. The fourth edition, published in 2011, marked a significant update after over three decades, reflecting advancements in medical science and pharmaceutical practices. It serves as an essential tool for physicians, pharmacists, and healthcare providers, offering standardized information on drug formulations, dosages, and therapeutic uses.​

This edition comprises 34 therapeutic chapters encompassing 591 drug monographs and 23 appendices, covering a wide array of medical conditions and treatment protocols. The NFI 2011 emphasizes evidence-based medicine, aligning with national health programs and the National List of Essential Medicines (NLEM) of India. It provides detailed information on drug indications, dosage forms, strengths, precautions, contraindications, adverse effects, and storage conditions, ensuring healthcare professionals have access to accurate and up-to-date therapeutic data.​

Notably, the NFI 2011 introduced several enhancements to improve its utility and relevance. A dedicated chapter on the management of diabetes was included, addressing the growing prevalence of the condition in India. The edition also incorporated guidelines on Good Distribution Practices, revised immunization schedules, and information on drugs banned in sports, reflecting a holistic approach to healthcare. These updates underscore the NFI’s commitment to supporting rational drug therapy and informed clinical decision-making.​

The National Formulary of India 2011 is a vital resource that consolidates expert knowledge and clinical guidelines to promote safe and effective medication use across the country. By providing standardized and evidence-based information, it aids in the rational selection and administration of medicines, contributing to improved patient outcomes and the advancement of public health in India.